TITLE:
A Study of Cabergoline for the Treatment of Cocaine Dependence - 1

CONDITION:
Cocaine-Related Disorders

INTERVENTION:
Cabergoline

SUMMARY:

      The purpose of this study is to assess cabergoline for the Treatment of Cocaine Dependence
    

DETAILED DESCRIPTION:

      To assess the efficacy and safety of cabergoline in reducing cocaine use in subjects with
      cocaine dependence. This is a DB, placebo-controlled, parallel group design study where
      subjects will receive either .5mg cabergoline or placebo for 12 weeks with a 4 week
      follow-up.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 99 Years
Criteria:

        Inclusion Criteria:

        Must have a DSM-4 criteria for cocaine dependence; be seeking treatment for cocaine
        dependence; have the ability to understand and provide written informed consent; females
        of child-bearing potential using proper method of birth control.

        Exclusion Criteria:

        Additional criteria available during screening at the site.
      
